CompoAtlas

Kirkland Signature Coenzyme Q10 300 mg

Kirkland Signature Coenzyme Q10 300 mg, NPN 80138820: natural health product licensed in Canada. Medicinal ingredients: 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl.

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl

Source : Rhodobacter sphaeroides - Whole

300 mgNot calculated

Non-medicinal ingredients

Gélatine, Glycérine, Huile de son de riz, d-alpha tocophérol, Pectine, Eau, Sorbitol

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Capsule1 Tous les jours

Uses authorised in Canada

Helps to maintain and/or support cardiovascular health. Helps to reduce the frequency of migraine headaches and associated nausea and vomiting when taken as a prophylactic/preventative.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Product record

Other names
Coenzyme Q10 300 mg, Coenzyme Q10 300 mg Extra Strength, Extra Strength Coenzyme Q10 300 mg, Kirkland Signature Coenzyme Q10 300 mg Extra Strength, Kirkland Signature Extra Strength Coenzyme Q10 300 mg
Licence holder
WN Pharmaceuticals Ltd
NPN or DIN-HM
80138820
Status
Active licence
Licence date
27 February 2025
Revision date
Not provided
Form
Capsule, libération retardée
Route of administration
Orale
Application type
Générale (non traditionelle)

Source

Official Health Canada record, licence 80138820

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Kirkland Signature Coenzyme Q10 300 mg (WN Pharmaceuticals Ltd): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80138820-kirkland-signature-coenzyme-q10-300-mg, updated 27 February 2025.

Enter to analyse, Shift+Enter for a new line